ArticleCell communication and signaling : CCS2026
Bendless-mediated K63 ubiquitination modulates cellular signalling to regulate Drosophila hematopoiesis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ubiquitination is a reversible modification whose traditional role has been associated with K48-linked polyubiquitination involved in proteasomal degradation. However, the role of K63-linked polyubiquitination has been explored in various cellular processes like DNA repair, endocytosis, innate immune response, kinase activation, etc. Since K63-linked poly-ubiquitination can regulate the stability, localization, and activity of its target molecules, its regulation and function in various developmental and disease contexts are being explored. Here, we investigate how K63 polyubiquitination regulates Drosophila blood cell homeostasis. Ubc13 (UBE2N), an E2 conjugating enzyme, is highly expressed in Acute Myeloid Leukemia (AML), wherein it controls innate immune signalling for the survival of AML cells; however, its role during developmental hematopoiesis is less explored. In Drosophila, Bendless is the functional homolog of Ubc13, whose role in stem cell regulation and particularly hematopoiesis is unknown. Our results indicate that spatial genetic perturbation of Bendless and its associated molecules, namely Uev1a, Effete, and E3 ligase - Traf6, that mediate K63 polyubiquitination are critical for maintaining hematopoietic progenitors and regulating their differentiation. We show that Bendless-mediated K63 polyubiquitination controls the Wingless signalling pathway by regulating Dishevelled in the larval lymph gland (LG) thereby modulating hematopoietic progenitor maintenance and differentiation. Furthermore, increased K63 polyubiquitination activates the JNK pathway in the LG, resulting in lamellocyte production. Genetic epistasis analysis shows that activation of the canonical Wingless pathway in the background of Bendless depletion or inactivation of the JNK pathway in Bendless over-expression conditions can restore physiological hematopoiesis. Our findings indicate that regulators of K63 polyubiquitination, like Bendless, could act as molecular inter-nodes that are capable of signalling cross-regulation, especially where intricate signalling networks are involved. Our study provides important mechanistic insights into the signalling mechanisms regulated by K63 polyubiquitination during stem cell homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.